Top Banner
SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based Medicine Unit FMUI – CMH, Jakarta
48
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

(”Bringing research evidence

into practice”)

Evidence-Based Medicine

Sudigdo Sastroasmoro

Clinical Epidemiology and Evidence-based Medicine Unit

FMUI – CMH, Jakarta

Page 2: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Evidence-based Medicine

• Medicine-based evidence

• Pragmatic research

• Outcome research

Related with

morbidity, mortality, quality of life

Page 3: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Value = Quality

Cost

Morbidity

Mortality

QoL

Patient

Satisfaction

Health

Status

Page 4: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Diagnosis

• Patient with complaint

• History

• Physical

• Simple test

• Specific test: If the test (+) what is the probability that the patient has the disease?

Yes or no answer

Predictive value is the most important

The spectrum of the presentations must resemble that in practice

Page 5: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Treatment

• Patient with certain diagnosis: best treatment?

• Is drug X more effective than Y?

• Focus on the clinical outcome, rather than its explanation (biomolecular markers, etc)

Yes or no outcome most useful

• Not in studies with “idealized” subjects Px with DM are frequently have

hypercholesterolemia, obese, hypertension, etc

Page 6: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Prognosis

• Usually in cohort studies

• To inform about the fate of the patient

• Absolute risk is more important than relative risk

Absolute: Your risk of having second stroke in 1 year is 30%

Relative: Your risk of having second stroke in 1 year is 2 times than in non-smokers (RR = 2)

Page 7: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Pros : “New paradigm in medicine” “Extraordinary innovations, only 2nd to Human Genome Project”

Cons : New version of an old song „Fair‟ : Nothing wrong with EBM, but:

• Be careful in searching evidence • Meta-analyses, clinical trials, and all

study results should be critically appraised

Keyword for EBM: Methodological skill to judge the validity

of study reports (Re. Andersen B: Methodo-logical errors in medical research, 1989)

Page 8: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

• Fletcher & Fletcher: CE = The application of epidemiologic principles in problems

encountered in clinical medicine • Sackett et al: CE = The basic science for clinical

medicine • Much resistance by experts • EBM: In principle – no one disagree • All major medical journals have adopted EBM • Centers for EBM all over the world

EBM & Clinical Epidemiology

Page 9: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Previous practice:

6 yrs medical education

40-50 yrs medical practice

Problems with patients: Dx, Rx, Px

Consultants, colleagues Textbooks Handbooks

Lecture notes Clinical guidelines CME, seminars, etc

Journals

Usu. see only Results section, or even worse, Abstract

section

Page 10: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

• Trust me

• In my experience ….

• Logically

• Textbook, handbook, capita selecta

Page 11: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

The results….

“Opinion-based medicine” • Steroid inj. in prematures to prevent RDS • Routine episiotomy • Routine circumcision • Antibiotics for flu-like syndrome • Use of immunomodulators • “Skin test” before antibiotic injection • Routine chest X-ray for pre-op preparation • CT scan after minor head trauma • etc ……

Page 12: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

What is Evidence-based Medicine?

• “The conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”

• “Pemanfaatan bukti mutakhir yang sahih dalam tata laksana pasien”

• Integration of (1) physician’s competence (2) valid evidence from studies (3) patient’s preference

Page 13: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

WHY EBM?

1 Information overload

2 Keeping current with literature

3 Our clinical performance deteriorates with time (“the slippery slope”)

4 Traditional CME does not improve clinical

performance

5 EBM encourages self directed learning process which should overcome the above shortages

Page 14: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Years after graduation

2 4 6 8 10 12

$

100%

THE SLIPPERY SLOPE

Page 15: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Our textbooks are out-of-date

• Fail to recommend Rx up to ten years after it’s been shown to be efficacious.

• Continue to recommend therapy up to ten years after it’s been shown to be useless.

Page 16: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

1. Formulate clinical problems in answerable questions

2. Search the best evidence: use internet or other on-

line database for current evidence

3. Critically appraise the evidence for

Validity (was the study valid?)

Importance (were the results clinically important?)

Applicability (could we apply to our patient?)

4. Apply the evidence to patient

5. Evaluate our performance

Steps in EBM practice

VIA

Page 17: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Diagnosis

(Determination of disease or problem)

Treatment

(Intervention necessary to help the patient)

Prognosis

(Prediction of the outcome of the disease)

Main area

Page 18: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

(I) Formulating clinical questions

Page 19: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

• A 2-year old boy presented with 6-day high fever, conjunctival injection without secretion, skin rash> blood test shows leukocytosis, high ESR, CRP +++. He was suspected to have Kawasaki disease. The pediatrician is aware of the use of immunoglobulin to prevent coronary involvement, but uncertain about the dosage or recent developments.

Page 20: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Medical students: (Background question)

• What is Kawasaki disease? • What is the etiology? • How it is diagnosed? • What is the treatment of choice? • Complications?

Page 21: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

House officers (Foreground question)

• In a child with KD, would immunoglobulin treatment, compared with no immunoglobulin, reduce the chance to develop coronary complication?

Page 22: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Foreground

questions

Background

questions

Experience with condition

Page 23: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Other examples

• In women with history of eclampsia, would administration of low-dose aspirin during pregnancy prevent eclampsia? (Prevention)

In young women with solitary thyroid nodule, can USG, compared with biopsy, differentiate between benign from malignant? (Diagnosis)

In women systemic lupus erythematosus, is history of congestive heart failure, compared with no heart failure, worsen the prognosis? (Prognosis)

Page 24: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Four elements of good clinical question: PICO

• The Patient or Problem

• The Intervention / Index

• Comparative intervention (if relevant)

• The Outcome

Page 25: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Four elements of a well constructed clinical question: PICO

P I C O

The main

intervention

considered

The

alternative

to compare

with the

intervention

Outcome

expected

from this

intervention?

Description

of patient

or problem

B e b r i e f a n d s p e c i f i c

Page 26: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Do all clinical questions contain 4 elements of PICO?

• No

• The C implies in the question - PIO

– Does temulawak increase appetite in undernourished children?

• Asking prevalence – PO

– How many percent of patients with TIA who subsequently develop stroke?

Page 27: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Relevance: Type of Evidence

• POE: Patient-oriented evidence

– mortality, morbidity, quality of life

• DOE: Disease-oriented evidence

– pathophysiology, pharmacology, etiology

Page 28: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

POEM

• Patient-Oriented

• Evidence

Page 29: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Comparing DOES and POEMs

Prostate

screening

PSA screening

detects prostate

Ca. early

? whether PSA

screening

mortality

DOE exists, but

POEM unknown

Antiarrhythmic

Therapy

Antihypertens.

Therapy

Drug A PVC

On ECG

Drug X BP

Drug X

mortality

Drug A >

mortality

DOE & POEM

contradicts

POEM agrees

With DOE

Example

DOE

POEM

Comment

Page 30: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

II

Searching the evidence

Page 31: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

III

Appraising the evidence: VIA

Page 32: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Validity: In Methods section:

– design, sample, sample size, eligibility criteria (inclusion, exclusion), sampling method, randomization method, intervention, measurements, methods of analysis, etc

Importance: In Results section

– characteristics of subjects, drop out, analysis, p value, confidence intervals, etc

Applicability: In Discussion section + our patient’s characteristics, local setting

VIA

Page 33: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

• Were the subjects randomized?

• Were all subjects received similar treatment?

• Were all relevant outcomes considered?

• Were all subjects randomized included in the analysis?

• Calculate CER, EER, RRR, ARR, and NNT

• Were study subjects similar to our patients in terms of prognostic factors?

Example: Critical appraisal for therapy

Page 34: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Hierarchy of evidence

Meta-analysis of RCT Large RCT Small RCT Non-Randomized trials Observational studies Case series / reports Anecdotes, expert, consensus

Level 1

Level 2

Level 3

Level 4

A

B

C

Rec Weight of

Scientific

Scrutiny

For complete description see www.cebm.net

Page 35: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Implementation of EBM practice: How to get started

1. Teaching EBM in medical schools / PPDS

Easier than to change the already existing attitude

Most important

May be included in formal curricula or integrated in

existing activities: ward rounds, on calls, case

presentations, group discussions, journal clubs, etc

2. Workshop for teaching staff

3. Workshop for practitioners, incl. nurses

Page 36: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Resistance to EBM teaching & learning

Rudimentary skill in critical appraisal /

methodological skill

Limited resources, esp. time factor

Lack of high quality evidence

Skepticism toward evidence-based practice

‘Happy’ with current practice

Page 37: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Page 38: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

The

EBM

Cycle

Patient

With problem

Formulate In answerable

question

Search the

evidence

Appraise The

evidence

Apply The

evidence

Page 39: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Criticism to EBM • EBM makes expensive medical care

• EBM cannot be implemented in developing countries

• EBM is costly and time consuming

• EBM ignore pathophysiology & reasoning

• EBM ignore experience and clinical judgment

• EB-guidelines etc interfere with professional autonomy

Page 40: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Criticism to EBM

EBM makes expensive medical care

Cf:

–Routine antibiotics for ARTI & diarrhea

–Liberal indication for C-section

–Unnecessary sophisticated procedures / exams

–Unnecessary / harmful treatment: steroid for recurrent cough

Page 41: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Criticism to EBM

EBM cannot be implemented in developing countries

– By definition EBM is implemented if it is implementable (patient’s preference and local condition) – for the benefit of the patients and the community

Page 42: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Criticism to EBM

EBM is costly and time consuming

– EBM does requires facilities at the cost of quality medical care!

– Cost benefit ratio should be assessed in individual and community levels

Page 43: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Criticism to EBM

EBM ignores pathophysiology & reasoning

– EBM encourages clinical reasoning in the light of valid and important evidence

– Pathophysiology and reasoning should be seen as hypothesis and should end-up in empirical evidence

Page 44: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Criticism to EBM

EBM ignore experience and clinical judgment

– Personal experience and clinical judgment are by no means can be eliminated

– EBM encourage detailed and systematic documentation of experience and judgment

– Subjective experience should be, whenever possible, translated into more objective measures

Page 45: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Criticism to EBM EB-guidelines interfere with professional autonomy

– Professional conduct (competence, altruism, openness, collegiality, ethics) is encouraged in EBM

– Every physician should develop their own practice attitude based on his/her profess-ionalism, valid evidence, and patient’s values

– Development of clinical guidelines and other standards of care should be seen as a guide and implemented according to clinical setting

Page 46: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Advantages of EBM • Encourages reading habit • Improves methodological skill (and

willingness to do research?!) • Encourages rational & up to date

management of patients • Reduces intuition & judgment in clinical

practice, but not eliminates them • Consistent with ethical and medico-legal

aspects of patient management

Page 47: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

End result

Self directed, life-long learning attitude

for high quality patient care

Page 48: 01.intro-ss.new.pdf

SS/EBM/IKA-UDIP-2010

Conclusion

EBM is nothing more than a framework of systematic use of current valid study results relevant to our patient